By Delphine Thizy, Coordinator of the francophone working group at the RBM Partnership to End Malaria and Stakeholder Engagement Senior Adviser at Target Malaria

Twenty years ago, The Global Fund was created to fight what were then the world's deadliest infectious diseases: HIV, tuberculosis (TB), and malaria. Since then, the partnership has invested more than US$55 billion, saving over 50 million lives and cutting the combined death rate from the three diseases by more than half in the countries where it invests. Ahead of its Seventh Replenishment cycle, The Global Fund is calling on the world to mobilize US$18 billion to save 20 million lives. Reaching this target will mean reducing malaria cases by 66% by 2026.

Photograph: The Global Fund to Fight AIDS, Tuberculosis and Malaria 

Even before the world was shaken by the COVID-19 pandemic, progress against malaria had stalled. Although the worst-case scenario projected by the World Health Organization (WHO) was avoided, according to the 2021 World malaria report, there were still an estimated 241 million malaria cases and 627 000 malaria deaths worldwide in 2020, with over 96% of these deaths occurring in Sub-Saharan Africa. Now more than ever, it is crucial that we mobilize to ensure The Global Fund’s replenishment target is met and that we can address this challenge.